Richard Parad, MD, MPH
Associate Professor, Neonatologist, Harvard Medical School and Brigham and Women’s Hospital
Term Ends July 2025
Richard Parad, MD, MPH, is an Associate Professor in the Department of Pediatrics at Harvard Medical School and a practicing Neonatologist in the Department of Pediatric Newborn Medicine at Brigham and Women's Hospital, Boston. He is dual-trained Neonatal-Perinatal Medicine and Pediatric Pulmonology.
As the Director of the Newborn Genomic Medicine Program, Parad utilizes his clinical knowledge, research experience, and understanding of state-of-the-art advances to implement the use of genomics in neonatal care, both through screening and diagnostics, with a goal of minimizing diagnostic odysseys and allowing for the earliest possible initiation of appropriate therapies that optimize outcomes in rare disorders, such as cystic fibrosis and Duchenne muscular dystrophy. He has been involved with public health newborn screening for over 20 years, and has recently involved patients and parents in the development of standards for genetic counseling of parents of newborns with positive newborn screening results.
He is also developing a model for telemedicine-based counseling resources for rare disorders to be able to comply with these guidelines and will make available information to families with limited access.
Conflicts of Interest
As of July 17, 2022:
- Brigham and Women’s Hospital, Member
- Harvard Medical School, Professor
- Cure Duchenne, Research Gift Recipient
- Ultragenyx, Research Grant Recipient
- Vertex, Research Grant Recipient, Co-Investigator
- Cystic Fibrosis Foundation, Research Grant Recipient, Co-Investigator
- Boston Children’s Hospital, Member, Spouse
- Advisory Panel Member
- Advisory Panel on Rare Disease